Actively Recruiting
Study of Dexmedetomidine Addition to Ultrasound-Guided Greater Occipital Nerve Block in Children Having Posterior Fossa Tumor Surgery
Led by Children's Cancer Hospital Egypt 57357 · Updated on 2026-10-16
260
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of different techniques for a nerve block called greater occipital nerve block GONB during surgery to remove tumors from the back part of the brain posterior fossa in children. The study aims to compare ultrasound-guided GONB with the blind technique and to see if adding the drug dexmedetomidine affects heart stability during surgery, opioid use, pain control, and the time before additional pain medicine is needed. Participants will be randomly assigned to one of four groups blind GONB with bupivacaine, blind GONB with bupivacaine plus dexmedetomidine, ultrasound-guided GONB with bupivacaine, or ultrasound-guided GONB with bupivacaine plus dexmedetomidine. All children will receive general anesthesia and bilateral nerve blocks according to their group during their scheduled tumor surgery. During the surgery and afterward, researchers will monitor heart rate, blood pressure, opioid use, and the time until the first request for extra pain relief. The main outcome measured is the mean arterial pressure after the nerve block injection during surgery. This study is expected to be completed by March 2027 and is sponsored by Childrens Cancer Hospital Egypt 57357.
CONDITIONS
Brief Title
Dexmedetomidine Use for Greater Occipital Nerve Block in Pediatric Posterior Fossa Tumor Surgery.
Research Team
N
Nancy Ashraf Abdellatif
D
Dina Elgalaly
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here